CORRECTING and REPLACING Ligand to Present at the Jefferies 2012 Global Healthcare Conference on June 4
Ligand to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on May 17
Ligand Pharmaceuticals Reports First Quarter Results
Ligand to Report First Quarter Results on May 2nd
Ligand to Present at the 24th Annual Roth Conference on March 12
Ligand to Present at the Citi Global Health Care Conference on February 28th
Ligand Licenses DARA Program to Retrophin
Ligand to Present at the BIO CEO and Investor Conference on February 13
Ligand Reports Fourth Quarter and Full Year 2011 Financial Results
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Presents Full Data from Successful Phase II Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings
Ligand to Report Fourth Quarter Results on February 7
Ligand to Present at the Biotech Showcase Conference on January 10th
Ligand Enters into Platform Captisol® License and Supply Agreements with Lilly
